Citi Starts Puma Biotechnology (PBYI) at Buy
Tweet
Share
E-mailGet Alerts PBYI Hot Sheet
Price: $9.55 +1.49%
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Citi initiated coverage on Puma Biotechnology (NYSE: PBYI) with a Buy rating and a price target of $123.00.
For an analyst ratings summary and ratings history on Puma Biotechnology click here. For more ratings news on Puma Biotechnology click here.
Shares of Puma Biotechnology closed at $73.37 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- StoneX Starts Lennar (LEN) at Hold
- Citi Starts Air China Ltd. (753:HK) (AIRYY) at Sell
- Citi initiates Dianthus Therapeutics coverage with Buy rating
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
